Growth Hormone Axis Genetics: IGF1, GHSR, and Aging

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on longevity and telomeres. Browse all Longevity & Telomeres education

Between the ages of 20 and 80, circulating growth hormone levels fall by roughly 50% — and IGF-1, the downstream messenger that carries most of GH's tissue repair and anabolic signaling, declines with it. This age-related decline of the GH axis, called somatopause, contributes to the progressive changes in body composition, recovery capacity, connective tissue integrity, and sleep architecture that characterize biological aging in most adults. How steeply that decline runs, and how effectively the axis functions at any given age, is shaped in part by the genes that govern it. The Precision Peptide Genetic Test analyzes GHSR, IGF1, and related variants as part of 17 Longevity & Aging insights, within a broader panel spanning 14 pathways, 49 peptides, and 150+ genetic insights. This post explains what each gene reveals — and how the growth hormone axis connects to longevity biology at the cellular level.

The Growth Hormone Axis — How It Works

The GH axis is a signaling cascade that begins in the hypothalamus and ends in virtually every tissue in the body. The hypothalamus releases growth hormone-releasing hormone (GHRH), which triggers the pituitary to secrete growth hormone (GH). GH travels through the bloodstream, binding to growth hormone receptors (GHR) on the liver and other tissues. The liver responds by producing IGF-1 (insulin-like growth factor 1), which acts as the primary downstream effector — promoting protein synthesis, cellular repair, fat mobilization, and tissue maintenance. Ghrelin, acting through GHSR (the growth hormone secretagogue receptor), provides a separate stimulatory input that amplifies GH pulse amplitude. Variants at GHSR, IGF1, and GHR determine how efficiently each step in this cascade translates into downstream biological effect.

GHSR — The Ghrelin Receptor Switch

GHSR encodes the receptor that responds to ghrelin — the "hunger hormone" that also serves as a potent GH secretagogue. When ghrelin binds GHSR on pituitary somatotrophs, it triggers a large-amplitude GH pulse. Common variants at GHSR (including rs572169 and rs2922126) influence receptor sensitivity and baseline GH pulse characteristics. A less sensitive GHSR variant doesn't eliminate GH secretion — it reduces the magnitude of each pulse and the cumulative daily GH output, which compounds over decades as somatopause progresses. Understanding your GHSR variant frames what baseline GH pulse architecture your axis is working with — relevant context for any growth hormone axis support conversation with a qualified healthcare provider.

IGF1 — The Downstream Signal

IGF-1 is where most of the GH axis's biological action actually happens. IGF-1 promotes cell survival, protein synthesis, muscle repair, bone metabolism, and fat mobilization — and its decline with somatopause is measurably associated with the loss of lean mass, reduced recovery, and diminished tissue regenerative capacity that characterize aging in most adults. The IGF1 gene contains a promoter microsatellite polymorphism (CA repeat length) that influences baseline IGF-1 transcription — with the 192-base-pair allele associated with higher circulating IGF-1 in multiple population studies. Other functional SNPs near the IGF1 locus further modulate expression and receptor sensitivity. Your IGF1 variant profile reveals where your genetically calibrated IGF-1 baseline sits — the ceiling your lifestyle and protocol inputs are working against or with.

The IGF-1 and Longevity Paradox — Held in Tension

The relationship between IGF-1 and longevity is among the most genuinely complex in aging biology. In rodent models, reducing IGF-1 signaling consistently extends lifespan. In human centenarian studies, some populations show lower IGF-1. Yet in most adult humans, higher IGF-1 within normal physiological range is associated with better muscle maintenance, faster recovery, lower all-cause mortality risk, and better cognitive aging. The resolution lies in context: extremely high IGF-1 promotes cellular proliferation at rates that may not be beneficial across very long time horizons, but IGF-1 that is low due to somatopause and insufficient GH stimulation is associated with the body composition, energy, and tissue repair deficits that make aging feel like aging. Your IGF1 genotype establishes your genetic floor — the baseline from which lifestyle and supportive interventions operate.

GHR — The Growth Hormone Receptor

Once GH is secreted, it must bind GHR on target tissues to produce any effect. GHR variants — particularly the exon 3 deletion (d3-GHR) — influence receptor sensitivity and downstream IGF-1 production per unit of circulating GH. d3-GHR carriers produce more IGF-1 from the same GH input, which means the same GH axis activity translates into more downstream anabolic signaling. This amplification effect matters in a longevity context: as somatopause reduces total GH output, the efficiency with which remaining GH signal converts into IGF-1 becomes proportionally more important. Understanding GHR status alongside GHSR and IGF1 completes the picture of your GH axis architecture from secretion through to cellular effect.

The GH Axis, SIRT1, and the Longevity Network

The growth hormone axis intersects with the broader longevity panel at several points. SIRT1 — whose NAD+-dependent activity we examined in L5 — deacetylates and modulates key components of the IGF-1 signaling pathway, including the FOXO transcription factors that IGF-1 suppresses. For the full SIRT1 and NAD+ pathway context, see the SIRT1 Pathway post. FOXO3 — the centenarian gene — sits directly downstream of IGF-1 in the aging cascade: when IGF-1 signaling is low, FOXO3 enters the nucleus and activates its cellular stress-defense programs. For the FOXO3 deep dive, see the FOXO3 Longevity Gene post. Your GHSR, IGF1, and GHR results inform how your GH axis feeds into these downstream longevity regulators. The Peptide Pathways Report synthesizes how growth hormone axis genetics interacts with the full longevity panel. For the complete longevity pathway overview, see the Complete Guide to Genetic Longevity Testing.

Genetics as a Guide, Not a Guarantee

A less sensitive GHSR variant or a lower-expressing IGF1 genotype doesn't determine your body composition trajectory or recovery capacity at 60. Lifestyle inputs — resistance training, sleep quality, adequate protein, and stress management — all modulate GH axis output substantially, regardless of genotype. What your GHSR, IGF1, and GHR results provide is a clearer picture of your genetic starting point: whether your axis is naturally more efficient or more constrained, and whether growth hormone axis support is likely to provide high or moderate leverage in your longevity strategy. That calibration is what testing before you invest in any longevity protocol is designed to deliver.

The Precision Peptide Genetic Test analyzes how your genes influence longevity and aging pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to see your longevity genetic profile? Take the Precision Peptide Genetic Test

Frequently Asked Questions

What does GHSR reveal about growth hormone and aging?

GHSR reveals how sensitively your pituitary responds to ghrelin's GH-stimulating signal — influencing GH pulse amplitude and daily output. As somatopause progresses, GHSR sensitivity shapes how effectively the axis compensates. Part of 17 Longevity & Aging insights in the Precision Peptide Genetic Test, spanning 14 pathways, 49 peptides, and 150+ total insights.

What does the IGF1 gene reveal about longevity?

IGF1 variants — including promoter microsatellite length — influence baseline IGF-1 transcription and circulating levels. IGF-1 is the primary downstream effector of GH axis signaling, governing tissue repair, lean mass maintenance, and metabolic function across the lifespan. The Precision Peptide Genetic Test analyzes IGF1 as part of 17 Longevity insights within 14 total pathways.

How does my GH axis genetic profile connect to longevity protocols?

Your GHSR, IGF1, and GHR results reveal whether your growth hormone axis is genetically efficient or constrained — informing how much leverage growth hormone axis support may provide. A less efficient axis may respond more meaningfully to support than a naturally high-output one. Results inform the conversation with a qualified provider, not prescriptions.

This article is part of the PlexusDx Education Hub. Browse all Longevity & Telomeres education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.